Jobs / United States / Sanofi US Services INC
DUPIXENT Health Economics and Value Assessment Business Partner VIE Contract
Sanofi US Services INC · 🇺🇸 Cambridge, MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles1 certified filing for “HEVA Bsns Partner-Respiratory & GI Indications, Rhinology Ld” (Management Analysts) in MA: $179k–$179k, median $179k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Last confirmed live 2 days agoWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
DUPIXENT Health Economics and Value Assessment Business Partner - VIE Contract • Location: United States of America, Cambridge • Target start date: 01/01/2027 iMove, the Sanofi VIE Program, is available to citizens of the European Economic Area (EU + Norway, Liechtenstein and Iceland) aged between 18 and 28. PLEASE NOTE that since this program is primarily an international development program, candidates cannot apply to a VIE assignment in their own country of citizenship. PLEASE NOTE that applications that are only submitted in French cannot be considered by our non-French speaking partners at Sanofi worldwide. Therefore, only applications that are submitted in English will be considered. Please make sure to apply with your personal email address. About the job As DUPIXENT Health Economics and Value Assessment Business Partner VIE within our Market Access team, you will contribute significantly, both in quantity and quality, to scientific work that the HEVA (Health Economics and Value Assessment) Respiratory/Rhinology/GI team delivers. DUPIXENT is the flagship of the Sanofi Specialty Care life changing Immunology Franchise. It is currently being launched worldwide for conditions including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and prurigo nodularis, with the ambition of becoming the treatment of choice for all type 2 inflammation diseases due to its innovative mode of action. The portfolio for this product includes 10+ indications currently being evaluated at various stages of clinical development. Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. Ready to get started? About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Main responsibilities: • Manage and execute health economics and outcomes research (HEOR) studies to support the clinical, economic, and humanistic value propositions of dupilumab across respiratory, rhinology and GI indications. Such studies may include core value dossier/ Academy of Managed Care Pharmacy (AMCP) dossier, burden of illness, epidemiology, literature review, real-world evidence, meta-analysis, economic models, and patient-reported outcomes. • Support contracting and project management activities. • Set evidence generation priorities and direction for assigned responsibilities and incorporate them into daily practice. • Support the Integrated Evidence Generation Plan and Brand Planning processes, supervised by HEVA Business Partners. • Develop and maintain collegial relationships with internal cross-functional global/US stakeholders and external alliance partners. A bout you Experience: • At least 1 year of previous experience in connection with this field. • Previous experience in Health Economics and Outcomes Research or Health Services Research would be a plus. • Solid experience with HEOR methodologies and applications is appreciated. Soft and technical skills: • Effective communication skills, both written and verbal, including presentation skills. • Agility and flexibility to adapt to ways of working within the organization. • Strong ability to partner with colleagues from other functional areas (Market Access & Pricing, Medical Affairs, Commercial). • Knowledge of and experience with Global